TMOD3 and hepatocellular carcinoma: The cleavage of Tmod3 was also detected in the hepatocellular carcinoma tissues (32.0%, 8 of 25 cases, Fig. 3E and Fig. S5D) and the cervical cancer tissues (26.7%, 8 of 30 cases, Fig. 3F and Fig. S5E).